8 reports

THE DRUG CANDIDATE IS A ## MER PEPTIDE ACTS BY TARGETING PROGRAMMED CELL DEATH ## LIGAND ## (PD-L##).

  • Blood Disease
  • Cardiovascular Disease
  • Lymphoma
  • Therapy
  • Bristol-Myers Squibb Company

Drug/ Molecule refers to Primary Intervention only. ##.

  • Cardiovascular Disease
  • Drug Development
  • Lymphoma
  • World
  • Otsuka Pharmaceutical Co., Ltd.

One patient had a fatal SAE, which was not drug related.

  • Cardiovascular Disease
  • Lymphoma
  • Pharmaceutical
  • United States
  • Product Initiative

PI##-Kinase delta is expressed primarily in blood cell lineages, including cells that cause or mediate hematologic malignancies, inflammation, autoimmune diseases and allergies.

  • Cardiovascular Disease
  • Lymphoma
  • Therapy
  • United States
  • Product Initiative

One patient had a fatal SAE, which was not drug related.

  • Blood Disease
  • Cardiovascular Disease
  • Lymphoma
  • United States
  • Product Initiative

THE ALLERGY AND IMMUNOLOGY CENTER IS HOME TO NATIONALLY AND INTERNATIONALLY RENOWNED EXPERTS AND RESEARCHERS WHO ARE ON THE FOREFRONT OF EVALUATING NEW METHODS OF ALLERGY TESTING AND TREATMENT, AND PAVING THE WAY IN THE FIELDS OF FOOD ALLERGY, DRUG

  • Cardiovascular Disease
  • Healthcare
  • Medical Device
  • Respiratory Monitoring
  • Market Size

Sanofi also offers consumer healthcare products for digestion; allergy; cough, cold, flu and sinus; pain; women' s health; and vitamins, minerals and supplements.

  • Blood Disease
  • Cardiovascular Disease
  • Hospital
  • Lymphoma
  • MediciNova, Inc.

One patient had a fatal SAE, which was not drug related.

  • Cardiovascular Disease
  • Lymphoma
  • Therapy
  • United States
  • Product Initiative